Cargando…
Cell-type-specific immune dysregulation in severely ill COVID-19 patients
| Autores principales: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Author(s).
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009498/ https://www.ncbi.nlm.nih.gov/pubmed/33789116 http://dx.doi.org/10.1016/j.celrep.2021.108943 |
| _version_ | 1783672886455697408 |
|---|---|
| author | Yao, Changfu Bora, Stephanie A. Parimon, Tanyalak Zaman, Tanzira Friedman, Oren A. Palatinus, Joseph A. Surapaneni, Nirmala S. Matusov, Yuri P. Chiang, Giuliana Cerro Kassar, Alexander G. Patel, Nayan Green, Chelsi E.R. Aziz, Adam W. Suri, Harshpreet Suda, Jo Lopez, Andres A. Martins, Gislâine A. Stripp, Barry R. Gharib, Sina A. Goodridge, Helen S. Chen, Peter |
| author_facet | Yao, Changfu Bora, Stephanie A. Parimon, Tanyalak Zaman, Tanzira Friedman, Oren A. Palatinus, Joseph A. Surapaneni, Nirmala S. Matusov, Yuri P. Chiang, Giuliana Cerro Kassar, Alexander G. Patel, Nayan Green, Chelsi E.R. Aziz, Adam W. Suri, Harshpreet Suda, Jo Lopez, Andres A. Martins, Gislâine A. Stripp, Barry R. Gharib, Sina A. Goodridge, Helen S. Chen, Peter |
| author_sort | Yao, Changfu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8009498 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | The Author(s). |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80094982021-03-31 Cell-type-specific immune dysregulation in severely ill COVID-19 patients Yao, Changfu Bora, Stephanie A. Parimon, Tanyalak Zaman, Tanzira Friedman, Oren A. Palatinus, Joseph A. Surapaneni, Nirmala S. Matusov, Yuri P. Chiang, Giuliana Cerro Kassar, Alexander G. Patel, Nayan Green, Chelsi E.R. Aziz, Adam W. Suri, Harshpreet Suda, Jo Lopez, Andres A. Martins, Gislâine A. Stripp, Barry R. Gharib, Sina A. Goodridge, Helen S. Chen, Peter Cell Rep Correction The Author(s). 2021-03-30 2021-03-30 /pmc/articles/PMC8009498/ /pubmed/33789116 http://dx.doi.org/10.1016/j.celrep.2021.108943 Text en © 2021 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correction Yao, Changfu Bora, Stephanie A. Parimon, Tanyalak Zaman, Tanzira Friedman, Oren A. Palatinus, Joseph A. Surapaneni, Nirmala S. Matusov, Yuri P. Chiang, Giuliana Cerro Kassar, Alexander G. Patel, Nayan Green, Chelsi E.R. Aziz, Adam W. Suri, Harshpreet Suda, Jo Lopez, Andres A. Martins, Gislâine A. Stripp, Barry R. Gharib, Sina A. Goodridge, Helen S. Chen, Peter Cell-type-specific immune dysregulation in severely ill COVID-19 patients |
| title | Cell-type-specific immune dysregulation in severely ill COVID-19 patients |
| title_full | Cell-type-specific immune dysregulation in severely ill COVID-19 patients |
| title_fullStr | Cell-type-specific immune dysregulation in severely ill COVID-19 patients |
| title_full_unstemmed | Cell-type-specific immune dysregulation in severely ill COVID-19 patients |
| title_short | Cell-type-specific immune dysregulation in severely ill COVID-19 patients |
| title_sort | cell-type-specific immune dysregulation in severely ill covid-19 patients |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009498/ https://www.ncbi.nlm.nih.gov/pubmed/33789116 http://dx.doi.org/10.1016/j.celrep.2021.108943 |
| work_keys_str_mv | AT yaochangfu celltypespecificimmunedysregulationinseverelyillcovid19patients AT borastephaniea celltypespecificimmunedysregulationinseverelyillcovid19patients AT parimontanyalak celltypespecificimmunedysregulationinseverelyillcovid19patients AT zamantanzira celltypespecificimmunedysregulationinseverelyillcovid19patients AT friedmanorena celltypespecificimmunedysregulationinseverelyillcovid19patients AT palatinusjosepha celltypespecificimmunedysregulationinseverelyillcovid19patients AT surapaneninirmalas celltypespecificimmunedysregulationinseverelyillcovid19patients AT matusovyurip celltypespecificimmunedysregulationinseverelyillcovid19patients AT chianggiulianacerro celltypespecificimmunedysregulationinseverelyillcovid19patients AT kassaralexanderg celltypespecificimmunedysregulationinseverelyillcovid19patients AT patelnayan celltypespecificimmunedysregulationinseverelyillcovid19patients AT greenchelsier celltypespecificimmunedysregulationinseverelyillcovid19patients AT azizadamw celltypespecificimmunedysregulationinseverelyillcovid19patients AT suriharshpreet celltypespecificimmunedysregulationinseverelyillcovid19patients AT sudajo celltypespecificimmunedysregulationinseverelyillcovid19patients AT lopezandresa celltypespecificimmunedysregulationinseverelyillcovid19patients AT martinsgislainea celltypespecificimmunedysregulationinseverelyillcovid19patients AT strippbarryr celltypespecificimmunedysregulationinseverelyillcovid19patients AT gharibsinaa celltypespecificimmunedysregulationinseverelyillcovid19patients AT goodridgehelens celltypespecificimmunedysregulationinseverelyillcovid19patients AT chenpeter celltypespecificimmunedysregulationinseverelyillcovid19patients |